Nuvectis Pharma, Inc. Shares Outstanding
Nuvectis Pharma, Inc. (NVCT) had Shares Outstanding of 26.69 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-04
- 2026-06-30: Shares outstanding (split-adjusted) 26.69M shares; Shares authorized (split-adjusted) 60.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 26.53M shares; Shares authorized (split-adjusted) 60.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 25.68M shares; Shares authorized (split-adjusted) 60.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 25.64M shares; Shares authorized (split-adjusted) 60.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 26.69M shares 10-Q · filed 2026-08-04 | 60.00M shares 10-Q · filed 2026-08-04 |
| 2026-03-31 | 26.53M shares 10-Q · filed 2026-05-05 | 60.00M shares 10-Q · filed 2026-05-05 |
| 2025-12-31 | 25.68M shares 10-Q · filed 2026-08-04 | 60.00M shares 10-Q · filed 2026-08-04 |
| 2025-09-30 | 25.64M shares 10-Q · filed 2025-11-04 | 60.00M shares 10-Q · filed 2025-11-04 |
| 2025-06-30 | 23.88M shares 10-Q · filed 2025-08-05 | 60.00M shares 10-Q · filed 2025-08-05 |
| 2025-03-31 | 23.63M shares 10-Q · filed 2025-05-06 | 60.00M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 19.50M shares 10-K · filed 2026-02-11 | 60.00M shares 10-K · filed 2026-02-11 |
| 2024-09-30 | 18.99M shares 10-Q · filed 2024-11-05 | 60.00M shares 10-Q · filed 2024-11-05 |
| 2024-06-30 | 18.75M shares 10-Q · filed 2024-08-06 | 60.00M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 18.36M shares 10-Q · filed 2024-05-07 | 60.00M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 17.42M shares 10-K · filed 2025-02-25 | 60.00M shares 10-K · filed 2025-02-25 |
| 2023-09-30 | 17.31M shares 10-Q · filed 2023-11-08 | 60.00M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 17.22M shares 10-Q · filed 2023-08-09 | 60.00M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | (m) | 60.00M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 15.19M shares 10-K · filed 2024-03-05 | 60.00M shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 14.64M shares 10-Q · filed 2022-11-08 | 60.00M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 12.72M shares 10-Q · filed 2022-08-10 | 60.00M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 12.72M shares 10-Q · filed 2022-05-12 | 60.00M shares 10-Q · filed 2022-05-12 |
| 2022-02-03 | (m) | 60.00M shares 10-K · filed 2024-03-05 |
| 2021-12-31 | 4.51M shares 10-K · filed 2023-03-08 | 12.87M shares 10-K · filed 2023-03-08 |
| 2021-05-31 | (m) | 12.87M shares 10-K · filed 2023-03-08 |
| 2020-12-31 | (m) | 3.90M shares 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |